Why the study?
The risk, predictors, and long-term benefits of prophylactic regimes for ventricular arrhythmia after successful CABG were not well defined.
Does EP-guided prophylaxis reduce sudden cardiac death compared to empirical antiarrhythmic medication in high-risk patients following CABG?
Cohort (n=8,642)
Does EP-guided prophylaxis reduce sudden cardiac death compared to empirical antiarrhythmic medication in high-risk patients following CABG?
Answers are grounded in this paper and cite their sources.
In patients with poor left ventricular function undergoing CABG, EP-guided prophylaxis significantly reduces the risk of sudden cardiac death compared to empirical antiarrhythmic therapy.
OBJECTIVES: We estimated the risk of sudden cardiac death (SCD), from a spontaneous episode of ventricular arrhythmia (VT/VF), after a successful surgical myocardial revascularization (coronary artery bypass grafting; CABG) procedure. Predictors of these events were identified, and long term benefits of the prophylactic regimes, that were used to control these events, were evaluated. METHODS: We selected 8642 consecutive patients, who had undergone an isolated and first time CABG procedure, between 1/3/1980 and 1/3/1995. A standard hazard function model (1) was used for statistical analysis. Efficacy of the prophylactic regimes, was examined in a group of 350 high risk patients, with a preoperative left ventricular ejection fraction 30% or less, who were recently operated since 1/1/1988. Electrophysiologic (EP) guided prophylaxis was used in 92 (26%) patients, who had survived a documented episode of SCD, and remaining 258 patients were maintained on antiarrhythmic medication on an empirical basis. A sequential EP evaluation was performed, when indicated. RESULTS: During an early phase of hazard, which mainly lasted for up to 3 months after CABG, incremental risk factors were preoperative LVEF 30% or less (P = 0.0007) and preoperative episodes of VT/VF (P = 0.04). This phase was followed by a constant phase with a low risk of the events, which merged into a slowly rising late phase after 6 years. EP guided prophylaxis, reduced the risk of SCD in high risk patients (P = 0.03). A sequential EP evaluation, helped to detect the problems of drug resistance and a cross over from non-sustained to sustained runs of VT/VF. CONCLUSIONS: Despite a successful CABG surgery, risk of VT/VF persists. A routine EP evaluation before and after a CABG procedure is recommended in all patients with a poor left ventricular function.
No takes yet. Share an insight, caveat, or question.
Kaul et al. (1998) conducted a cohort in Post-myocardial revascularization (CABG) (n=8,642). Electrophysiologic (EP) guided prophylaxis vs. Empirical antiarrhythmic medication was evaluated on Sudden cardiac death (SCD) (p=0.03).
Synapse has enriched 10 related papers. Consider them for comparative context: